Loading provider…
Loading provider…
Rheumatology Physician in West Hollywood, CA
NPI: 1417908229Primary Practice Location
CEDARS-SINAI MEDICAL CENTER
8700 Beverly Blvd, Los Angeles, CA
Primary Employer
Cedars-Sinai Medical Center
cedars-sinai.org
HQ Phone
Get M.D. Francesco's Phone Numberphone_androidMobile
Get M.D. Francesco's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
MD State Medical License
MD State Medical License
2006 - 2016
MN State Medical License
2002 - 2003
CA State Medical License
2015 - 2026
OR State Medical License
2020 - 2022

American Board of Internal Medicine
Rheumatology
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Residency • Internal Medicine
2000 - 2003
Johns Hopkins University
Fellowship • Rheumatology
2003 - 2006
University of Padua College of Medicine
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 40 | 91 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 17 | 17 |
| 3 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 16 | 16 |
Authors: Cottrell, Tricia R, Wise, Robert A, Wigley, Fredrick M, Boin, Francesco
Journal: Ann Rheum Dis
Publication Date: 2013-04-20
Understanding, assessing and treating Raynaud's phenomenon.
Authors: Boin, Francesco, Wigley, Fredrick M
Journal: Curr Opin Rheumatol
Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?
Authors: Francesco Boin, Fredrick M. Wigley
Publication Date: 2009-07
Lead Sponsor: Civi Biopharma, Inc.
Intervention / Treatment: DRUG: Iloprost Injection, for intravenous use, DRUG: Placebo IV infusion
Lead Sponsor: Civi Biopharma, Inc.
Intervention / Treatment: DRUG: Iloprost Injection, for intravenous use, DRUG: Placebo IV infusion
Lead Sponsor: Michael Roth
Collaborators: Genentech, Inc., University of California, Los Angeles, University of Michigan
Intervention / Treatment: DRUG: Mycophenolate Mofetil (MMF), DRUG: Pirfenidone (PFD), DRUG: Placebo (Plac)